Preparation and evaluation of 2-(allylthio)pyrazine-loaded lipid emulsion with enhanced stability and liver targeting

Drug Development and Industrial Pharmacy

Volumn 35, Issue 3, 2009, Pages 363-368

  Jang, Jun Hee ^a   Kim, Chong Kook ^a   Choi, Han Gon ^b   Sung, Jung Hoon ^b  

^a Seoul National University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

2 (allylthio)pyrazine; Lipid emulsion; Liver targeting; Pharmacokinetics; Stability

Indexed keywords

2 (ALLYLTHIO)PYRAZINE; LIPID EMULSION; PHOSPHATIDYLCHOLINE; SOYBEAN OIL; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG STABILITY; DRUG TARGETING; LIVER; MALE; NONHUMAN; RAT; TISSUE DISTRIBUTION;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; ENZYME INHIBITORS; FAT EMULSIONS, INTRAVENOUS; LECITHINS; LIVER; MALE; PARTICLE SIZE; PYRAZINES; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SOYBEAN OIL; TISSUE DISTRIBUTION;

EID: 61649114706     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802363696     Document Type: Article

References (25)

1. Constantinides, P. P., & Yiv, S. H. (1995). Particle size determination of phase-inverted water-in-oil microemulsions under different dilution and storage conditions. Int. J. Pharm., 115, 225-234.
2. Costa, S., Utan, A., Speroni, E., Cervellati, R., Piva, G., Prandini, A., & Guerra, M. C. (2007). Carnosic acid from rosemary extracts: A potential chemoprotective agent against aflatoxin B1. An in vitro study. J. App. Toxicol., 27(2), 152-159.
3. Driscoll, D. F. (2006). Lipid injectable emulsions: Pharmacopeial and safety issues. Pharm. Res., 23(9), 1959-1969.
4. Floyd, A. G. (1999). Top ten considerations in the development of parenteral emulsions. Pharm. Sci. Technol. Today, 4(2), 134-143.
5. Gibaldi, M., & Perrier, D. (1982). Pharmacokinetics (2nd ed.). New York: Marcel-Dekker.
6. Gursoy, R. N., & Benita, S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother., 58(3), 173-182.
7. Ha, T. G., & Kim, N. D. (1998). 2-AP inhibition of aflatoxin B1-induced hepatoxocity and its covalent DNA binding in rats by inhibition of cytochrome P450 2B and 3A2. Res. Commun. Mol. Path. Pharmacol., 102, 69-78.
8. Han, K. S., & Lee, M. G. (1999). Pharmacokinetics of chemopreventive agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: Hepatic and gastric first pass effects. Drug Metab. Dispos., 27, 221-226.
9. Ha, T. G., Jang, J. J., Kim, S. G., & Kim, N. D. (1999). 2-(Allylthio) pyrazine inhibition of afatoxin B1-induced hepatocarcinogenesis in rats. Chem. Bio. Interact., 121, 209-222.
10. Hwang, S. R., Lim, S. J., Park, J. S., & Kim, C. K. (2004). Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int. J. Pharm., 276(1-2), 175-183.
11. Kang, K. W., Ha, J. R., Kim, C. W., Kim, N. D., & Kim, S. G. (2001). 2-(Allylthio)pyrazine, a cancer chemopreventive agent, inhibits liver fibrosis induced by dimethylnitrosamine in rats: Role of inhibition of transforming growth factor-β1 expression. Pharmacol. Toxicol., 89, 23-29.
12. Kim, N. D., Kim, S. G., & Kwak, M. K. (1994). Enhanced expression of rat microsomal epoxide hydrolase gene by organosulfur compounds. Biochem. Pharmacol., 47, 541-547.
13. Kim, Y. G., Cho, M. K., Kwon, J. W., Kim, D. H., Kim, S. G., & Lee, M. G (1997). Effects of cysteine on the pharmacokinetics of intravenous 2-(allylthio) pyrazine, a new chemoprotective agent, in rats with protein-calorie malnutrition. Int. J. Pharm., 225, 1-11.
14. Kim, N. D., Kwak, M. K., & Kim, S. G. (1999). Inhibition of cytochrome P450 2E1 expression by 2-(allylthio) pyrazine, a potential chemoprotective agent: Hepatoprotective effects. Biochem. Pharmacol., 53, 261-269.
15. Kwak, M. K., Lee, W. I., Kim, N. D., & Lee, M. G. (1998). Metabolic changes of acetaminophen after intravenous administration to rats pretreated with 2-(allylthio)pyrazine. Biopharm. Drug Dispos., 19, 273-277.
16. Laval-Jeantet, A. M., Laval-Jeantet, M., & Bergot, C. (1982). Effects of particle size on the tissue distribution of iodized emulsified fat following intravenous administration. Invest. Radiol., 17, 617-620.
17. Lee, E. J., Kim, E. J., Kim, Y. G., Chung, H. C., Kim, S. H., Kim, D. H., Lees, I., Kim, S. G., & Lee, M. G. (2004). Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of 2-(allylthio) pyrazine, a chemoprotective agent, in rats: The role of CYP3A23 induction. Res. Commun. Mol. Pathol. Pharmacol., 115-116, 111-121.
18. Liu, D., Mori, A., & Huang, L. (1992). Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. Biochem. Biophys. Acta, 1104, 95-101.
19. Sha, X., Yan, G. Li, J., & Fang, X. (2005). Effect of self microemulsifying drug delivery systems containing Labrasol on tight junction in Caco-2 cells. Eur. J. Pharm. Sci., 24(5), 477-486.
20. Society of Toxicology (SOT). (1999). Guilding principles in the use of animals in toxicology, Available from www.toxicology.org/AI/FA/ guidingprinciples.pdf.
21. Surh, Y. J., Kim, S. G., Park, K. K., Sohn, Y. W., Lee, J. M., Kim, N. D., & Miller, J. A. (1998). Chemopreventive effects of 2-(allylthio)pyrazine on hepatic lesion, mutagenesis, and tumorigenesis induced by vinyl carbamate or vinylcarbamate epoxide. Carcinogenesis, 19, 3263-3267.
22. Tamilvanan, S. (2004). Oil-in-water lipid emulsions: Implications for parenteral and ocular delivering systems. Prog. Lipid Res., 43, 489-533.
23. Von, C. C., Thoren, P., & Engstrom, S. (1998). Triglyceride-based microemulsion for intraveous administration of sparingly soluble substances. J. Pharm. Sci., 87, 200-208.
24. Yim, Y. G., Cho, M. K., Kwon, J. W., Kim, D. H., Kim, S. G., & Lee, M. G. (2003). Effects of cysteine on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in rats with protein-calorie malnutrition. Int. J. Pharm., 255(1-2), 1-11.
25. Yong, C. S., Yang, C. H., Rhee, J. D., Lee, B. J., Kim, D. C., Kim, D. D., Kim, C. K., Choi, J. S., & Choi, H. G. (2004). Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol. Int. J. Pharm., 269, 169-176.